Litcius/Paper detail

Combined use of microwave ablation and cell immunotherapy induces nonspecific immunity of hepatocellular carcinoma model mice

Xuhua Duan, Manzhou Wang, Xinwei Han, Jianzhuang Ren, Guo‐Hao Huang, Shuguang Ju, Qinghui Zhang

2020Cell Cycle52 citationsDOIOpen Access PDF

Abstract

cells in the tumors and spleens of mice. The expressions of related cytokines were detected and measured by ELISPOT and ELISA. The results showed that MWA combined with anti-PD-1/anti-CTLA-4 not only increased the survival time, protected the mice against tumor recurrence, but also enhanced the intratumoral infiltration of cytotoxic T lymphocyte and systemic T-cell immune responses induced by MWA through activation of synergistically specific antitumor immunity. In addition, the combined therapy increased T-helper 1 cell (Th1-type) cytokines, but reduced Th2-type cytokines, resulting in the polarization of Th1 cells. T-cell immune responses of HCC cells were activated by MWA. In addition, the combined therapy of MWA and anti-PD-1/anti-CTLA-4 induced Th1-type immune response, and showed specific antitumor immunity.

Topics & Concepts

ImmunotherapyMicrowave ablationELISPOTCD8Hepatocellular carcinomaCancer researchImmune systemT cellCytotoxic T cellDendritic cellImmunologyFlow cytometryMedicineBiologyInternal medicineAblationIn vitroBiochemistryCancer Immunotherapy and BiomarkersHepatocellular Carcinoma Treatment and PrognosisImmunotherapy and Immune Responses